WallStSmart

ICL Israel Chemicals Ltd (ICL)vsScotts Miracle-Gro Company (SMG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ICL Israel Chemicals Ltd generates 121% more annual revenue ($7.71B vs $3.48B). ICL leads profitability with a 4.0% profit margin vs 2.1%. SMG appears more attractively valued with a PEG of 0.81. ICL earns a higher WallStSmart Score of 59/100 (C).

ICL

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 5.0Value: 4.7Quality: 6.0
Piotroski: 2/9Altman Z: 2.13

SMG

Hold

48

out of 100

Grade: D+

Growth: 2.7Profit: 5.5Value: 5.3Quality: 6.5
Piotroski: 5/9Altman Z: 1.90
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ICLUndervalued (+0.5%)

Margin of Safety

+0.5%

Fair Value

$5.78

Current Price

$5.36

$0.42 discount

UndervaluedFair: $5.78Overvalued
SMGSignificantly Overvalued (-17.5%)

Margin of Safety

-17.5%

Fair Value

$57.20

Current Price

$52.36

$4.84 premium

UndervaluedFair: $57.20Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ICL3 strengths · Avg: 9.3/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
51.6%10/10

Earnings expanding 51.6% YoY

Revenue GrowthGrowth
16.5%8/10

16.5% revenue growth

SMG2 strengths · Avg: 9.0/10
Debt/EquityHealth
-10.1310/10

Conservative balance sheet, low leverage

PEG RatioValuation
0.818/10

Growing faster than its price suggests

Areas to Watch

ICL4 concerns · Avg: 2.8/10
Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
9.442/10

Expensive relative to growth rate

SMG4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
1.1%4/10

1.1% revenue growth

Altman Z-ScoreHealth
1.904/10

Grey zone — moderate risk

Profit MarginProfitability
2.1%3/10

2.1% margin — thin

Return on EquityProfitability
-47.6%2/10

ROE of -47.6% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth, Revenue Growth. Revenue growth of 16.5% demonstrates continued momentum.

Bull Case : SMG

The strongest argument for SMG centers on Debt/Equity, PEG Ratio. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : ICL

The primary concerns for ICL are Return on Equity, Profit Margin, Piotroski F-Score. Thin 4.0% margins leave little buffer for downturns.

Bear Case : SMG

The primary concerns for SMG are Revenue Growth, Altman Z-Score, Profit Margin. Thin 2.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

ICL profiles as a growth stock while SMG is a value play — different risk/reward profiles.

SMG carries more volatility with a beta of 1.81 — expect wider price swings.

ICL is growing revenue faster at 16.5% — sustainability is the question.

SMG generates stronger free cash flow (307M), providing more financial flexibility.

Bottom Line

ICL scores higher overall (59/100 vs 48/100) and 16.5% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Scotts Miracle-Gro Company

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Scotts Miracle-Gro Company manufactures, markets, and sells lawn and garden products to consumers in the United States and internationally. The company is headquartered in Marysville, Ohio.

Visit Website →

Want to dig deeper into these stocks?